Literature DB >> 34822175

Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.

Patrick W Mellors1, Taxiarchis Kourelis2,3, Ronald S Go2, Eli Muchtar2, Morie A Gertz2, Shaji K Kumar2, Francis K Buadi2, Prashant Kapoor2, Martha Q Lacy2, David Dingli2, Yi Hwa2, Amie Fonder2, Miriam Hobbs2, Suzanne Hayman2, Rahma Warsame2, Nelson R Leung2, Yi Lin2, Wilson Gonsalves2, Mustaqeem Siddiqui2, Robert A Kyle2, S Vincent Rajkumar2, Angela Dispenzieri2,3.   

Abstract

Thromboses are prevalent in POEMS syndrome, but few risk factors for POEMS-associated thrombosis have been identified. The objective of this study is to identify novel risk factors for POEMS-associated thrombosis. In this retrospective cohort of 230 POEMS patients, 27% developed thrombosis. Arterial events were slightly more common than venous. Stroke accounted for 26% of all thromboses and 53% of arterial events. There were differences in baseline features between the thrombosis group and the no thrombosis group, and these were driven by patients with arterial thrombosis. Risk factors for arterial thrombosis included thrombocytosis, elevated hemoglobin/hematocrit, extravascular volume overload, and splenomegaly. Hyperprolactinemia appeared to be a risk factor for venous thrombosis. The risk of thrombosis was most striking among men with elevated hemoglobin (32% vs. 5%, p < .001) and hematocrit (42% vs. 5%, p < .001) compared to men without. Most thromboses occurred prior to POEMS directed therapy, and most that occurred during therapy happened within 3 months of diagnosis. Twenty-one percent of patients with thrombosis had recurrence. In recognition of high overall rates of thrombosis in this population, all patients with POEMS syndrome should receive prophylactic antiplatelet therapy, and clinicians should consider anticoagulation in patients with risk factors for POEMS-associated thrombosis.
© 2021 Wiley Periodicals LLC.

Entities:  

Mesh:

Year:  2021        PMID: 34822175      PMCID: PMC8738145          DOI: 10.1002/ajh.26422

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  20 in total

Review 1.  Acute arterial obliteration: a new feature of the POEMS syndrome?

Authors:  P Lesprit; F J Authier; R Gherardi; L Bélec; D Paris; D Melliere; A Schaeffer; B Godeau
Journal:  Medicine (Baltimore)       Date:  1996-07       Impact factor: 1.889

2.  Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

Authors:  Alessandra Carobbio; Juergen Thiele; Francesco Passamonti; Elisa Rumi; Marco Ruggeri; Francesco Rodeghiero; Maria Luigia Randi; Irene Bertozzi; Alessandro M Vannucchi; Elisabetta Antonioli; Heinz Gisslinger; Veronika Buxhofer-Ausch; Guido Finazzi; Naseema Gangat; Ayalew Tefferi; Tiziano Barbui
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

3.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

4.  Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.

Authors:  Elie Naddaf; Angela Dispenzieri; Jay Mandrekar; Michelle L Mauermann
Journal:  Muscle Nerve       Date:  2015-08-08       Impact factor: 3.217

5.  Ischemic stroke in patients with POEMS syndrome.

Authors:  Jun Feng; Xue-Min Gao; Hao Zhao; Tian-Hua He; Cong-Li Zhang; Kai-Ni Shen; Lu Zhang; Xin-Xin Cao; Ming Qian; Dao-Bin Zhou; Jian Li
Journal:  Blood Adv       Date:  2020-07-28

6.  POEMS syndrome, arterial thrombosis and thrombocythaemia.

Authors:  T Zenone; Y Bastion; G Salles; C Rieux; D Morel; P Felman; D Espinouse; P A Bryon; B Coiffier
Journal:  J Intern Med       Date:  1996-08       Impact factor: 8.989

Review 7.  Thrombocytosis and thrombosis.

Authors:  Alessandro M Vannucchi; Tiziano Barbui
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

8.  Acute carotid obliteration: a new vascular manifestation in POEMS syndrome.

Authors:  M E Erro; F Lacruz; N Aymerich; T Ayuso; G Soriano; J Gállego; J A Villanueva
Journal:  Eur J Neurol       Date:  2003-07       Impact factor: 6.089

Review 9.  POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature.

Authors:  W J Manning; A L Goldberger; R E Drews; B J Goldstein; J K Matheson; S L Rabinowe; D E Trentham; L Landsberg
Journal:  Semin Arthritis Rheum       Date:  1992-12       Impact factor: 5.532

10.  Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.

Authors:  Marina Scarlato; Stefano Carlo Previtali; Marinella Carpo; Davide Pareyson; Chiara Briani; Roberto Del Bo; Eduardo Nobile-Orazio; Angelo Quattrini; Giacomo Pietro Comi
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.